Cultured Meat Ingredients Market - A Regional and Global Analysis - Analysis and Forecast, 2023-2028

Table of Contents

1. Markets

• 1.1. Industry Outlook
  • 1.1.1. Market Definition
  • 1.1.2. Alternate Protein Trends
    • 1.1.2.1. Alternate Protein: Current and Future
      • 1.1.2.1.1. Advantages of Alternate Protein in Large-Scale Manufacturing
      • 1.1.2.1.2. Disadvantages of Alternate Protein in Large-Scale Manufacturing
    • 1.1.2.2. Developments in Cell Engineering
    • 1.1.2.3. Exploration of Environmental Benefits of Alternate Protein
    • 1.1.2.4. Emerging Start-ups in the Sector
      • 1.1.2.4.1. Key Countries to Focus
      • 1.1.2.4.2. Research and Development Programs Supported by Governments and Investors
    • 1.1.2.5. Other Industrial Trends
      • 1.1.2.5.1. Hybrid Products
      • 1.1.2.5.2. Fast-Food and Restaurant Partnerships
      • 1.1.2.5.3. Cultured Dairy and Eggs
      • 1.1.2.5.4. Bioinformatics and Data-Driven Approaches
  • 1.1.3. Ecosystem / Ongoing Programs
    • 1.1.3.1. Consortiums and Associations
    • 1.1.3.2. Regulatory Landscape
    • 1.1.3.3. Government Initiatives
  • 1.1.4. Alternate Protein: Cost Analysis

(Note: This section talks about the costs comparison between plant-based, cultivated, and fermented meat alternatives)

• 1.2. Business Dynamics
  • 1.2.1. Business Drivers
  • 1.2.2. Barriers in the Commercialization of Cultivated Meat

(Note: This section covers the scientific/economical/cultural/regulatory barriers faced by Cultured Meat companies)

• 1.2.3. Market Strategies and Developments
  • 1.2.3.1. Business Strategies
    • 1.2.3.1.1. Product Developments
    • 1.2.3.1.2. Market Developments
  • 1.2.3.2. Corporate Strategies
    • 1.2.3.2.1. Mergers & Acquisitions
    • 1.2.3.2.2. Partnerships, Joint Ventures, Collaborations & Alliances
  • 1.2.3.3. Others
• 1.2.4. Business Opportunities

(Note: This segment consists of the analysis of the stakeholders in the Cultured Meat Ingredients and Equipment and equipment market. This will include equipment manufacturers such as Liberation Labs, ingredient manufacturers such as Matrix F.T., and others)

• 1.3. Stakeholder Analysis
• 1.4. Investment Landscape
  • 1.4.1. Key Investors
  • 1.4.2. Major Fundings

2. Application

• 2.1. Cultured Meat Ingredients and Equipment Market - (by Application)
  • 2.1.1. Cultured Meat Ingredients and Equipment Market, by End-User Industry
    • 2.1.1.1. Fermentation
    • 2.1.1.2. Other Alternate Meat Manufacturers
    • 2.1.1.3. Cell Engineering
    • 2.1.1.4. Others

(Note: These are tentative applications. Subject to change as per further research and analysis)

• 2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Application)
  • 2.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by End-User Industry

3. Products

• 3.1. Cultured Meat Ingredients and Equipment Market - (by Product)
  • 3.1.1. Cultured Meat Ingredients and Equipment Market, by Origin
    • 3.1.1.1. Animal-derived (such as Gelatin and Collagen)
    • 3.1.1.2. Plant-derived (such as Cellulose and Alginate)
    • 3.1.1.3. Synthetic (such as Synthetic Peptide Hydrogels)
  • 3.1.2. Cultured Meat Ingredients and Equipment Market, by Type of Starter Cells
    • 3.1.2.1. Skeletal Muscle Stem Cells
    • 3.1.2.2. Fibroblasts
    • 3.1.2.3. Embryonic Stem Cells
    • 3.1.2.4. Others (such as Adipose-Derived Cells, Mesenchymal Stem Cells, and Induced Pluripotent)
• 3.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Product)
  • 3.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Origin
  • 3.2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Type of Starter Cell
• 3.3. Supply Chain Analysis/Value Chain Analysis

(Note: The report will cover either the Supply Chain Analysis or Value Chain Analysis, depending upon data availability)

• 3.4. Patent Analysis

4. Region

• 4.1. Global Alternate Protein Outlook
• 4.2. North America
  • 4.2.1. North America (by Country)
    • 4.2.1.1. U.S.
    • 4.2.1.2. Canada
    • 4.2.1.3. Rest-of-North America
• 4.3. Europe
  • 4.3.1. Europe (by Country)
    • 4.3.1.1. Netherlands
    • 4.3.1.2. Israel
    • 4.3.1.3. Germany
    • 4.3.1.4. France
    • 4.3.1.5. Rest-of-Europe
• 4.4. U.K.
• 4.5. China
• 4.6. Asia-Pacific
  • 4.6.1. Asia-Pacific (by Country)
    • 4.6.1.1. Japan
    • 4.6.1.2. South Korea
    • 4.6.1.3. Singapore
    • 4.6.1.4. Rest-of-Asia-Pacific
• 4.7. Rest-of-the-World
  • 4.7.1. Rest-of-the-World (by Region)
    • 4.7.1.1. South America
    • 4.7.1.2. Middle East and Africa
      • 4.7.1.2.1. Israel

5. MARKETS -Competitive Benchmarking & Company Profiles

• 5.1. Competitive Benchmarking
  • 5.1.1. Competitive Position Matrix
  • 5.1.2. Market Share Analysis
    • 5.1.2.1. Ingredient Manufacturers
    • 5.1.2.2. Equipment Manufacturers
• 5.2. Company Profiles
  • 5.2.1. Ingredient Manufacturers
    • 5.2.1.1. AMSBIO
      • 5.2.1.1.1. Company Overview
      • 5.2.1.1.2. Product Portfolio
      • 5.2.1.1.3. Customer Profile
        • 5.2.1.1.3.1. Key Customers
        • 5.2.1.1.3.2. Target Customers
      • 5.2.1.1.4. Analyst View

Note: Similar Details will be provided for below mentioned companies.

• 5.2.1.2. Bright Biotech
• 5.2.1.3. BioBetter
• 5.2.1.4. Extracellular
• 5.2.1.5. IntegriCulture Inc.
• 5.2.1.6. Matrix F.T.
• 5.2.1.7. SeaWith Inc.
• 5.2.1.8. Sartorius AG
• 5.2.1.9. Multus Biotechnology

• 5.2.2. Equipment Manufacturers
  • 5.2.2.1. CELLULAR AGRICULTURE LTD
  • 5.2.2.2. Liberation Labs
  • 5.2.2.3. Prolific Machines

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
• 6.2. Data Triangulation
• 6.3. Market Estimation & Forecast
  • 6.3.1. Factors for Data Prediction and Modelling